Cancer is, at bottom, a theft of time. Everything else about the disease, the pain, the treatments, the vocabulary of battle we drape over it, is detail. The crime itself is that years you were owed are taken. So imagine the strange morning when medicine announces that it has finally caught the thief, completely, for every patient, every type, every stage. One injection, one course, done. And then the physician slides the consent form across the desk, because the cure has a price, and the price is half of whatever time you had left.

Not half your money. Half your remaining lifespan, surrendered with certainty, in exchange for certainty. The disease that steals time can now be stopped by a treatment that charges it. Before dismissing the premise as science fiction cruelty, it is worth noticing that medicine has been running a version of this trade for eighty years.

The first chemotherapy was a weapon. In the 1940s, researchers at Yale noticed that mustard gas, the horror of the trenches, annihilated the white blood cells of exposed soldiers, and they reasoned with grim elegance that a poison which kills blood cells might be aimed at blood cancers. Nitrogen mustard became the first chemotherapeutic agent, and the founding logic of the entire field was set: poison the patient and the tumor together, and bet that the tumor dies first. Radiation cures cancers and causes them, sometimes in the same body, decades apart. The radical mastectomy bought survival with mutilation for nearly a century. Modern regimens still trade heart damage, nerve damage, second malignancies, and years of life quietly shaved off the far end, and every oncologist knows it, and every consent form says it in paragraphs nobody reads.

In other words, the price was always there. It was simply unknowable, scattered, probabilistic, hidden in the far future where medicine’s accounting rarely reaches. The scenario’s cure does not introduce the trade. It itemizes it. And an itemized price changes everything, because a hidden cost is a risk, while a printed one is a choice.

Now watch what the arithmetic does, because it is stranger than it first appears. The price inverts medicine’s entire moral geography. A seventy-eight-year-old with perhaps eight years left pays four of them, and signs before the pen is fully offered. A thirty-year-old with fifty-five years ahead pays twenty-seven, and sits in the parking lot unable to turn the key. And a child, a child with seventy years owed, can be saved at the cost of thirty-five of them, which means the darkest room in medicine is no longer the one where parents are told nothing can be done. It is the one where they are told exactly what can be done, and asked to sign away half of a life that is not theirs, on behalf of someone who will one day be fifty and doing the subtraction.

There is a second clause in the contract, quieter and possibly heavier. Whoever takes the cure walks out knowing, within a narrow band, when they will die. Cancer’s cruelty was uncertainty, and the cure’s cruelty is the opposite. It replaces the ambush with an appointment. Medicine has never sold that before.

So the scenario assembles itself once again. Lets say now , By the 2060s the treatment is universal and the culture has given it a plain name, the Trade, and an entire profession has grown up around the signature, counselors who are part actuary, part chaplain, walking families through a decision that is arithmetic on paper and theology in the chest. Some take it instantly. Some refuse it and gamble on the old slow treatments, keeping their years and their uncertainty together. And a new kind of person moves through society, the Traded, people who know their date, who plan backward from it, who finish things. Their weddings are earlier. Their forgiveness is faster. Around them, unexpectedly, the old memento mori culture comes back from the museums, because half the population now lives the way monks once advised, with the hourglass on the desk.

The Fork

So the question is which way this breaks. One path treats the Trade as the most serious act of sovereignty a person can perform, and builds the walls to match. The date is sealed absolutely, unpriceable and unsubpoenable. The counseling is real and unhurried. The old treatments stay funded so that the Trade is a choice rather than a budget’s preference, and no parent decides alone. On this path, the strange gift inside the bargain gets kept, a civilization relearning, from the Traded, how to finish lives on purpose rather than merely having them end.

The other path is the actuarial one. The cure becomes the default because it is cheap and final, the systems quietly narrow the alternatives, the young poor sign because the counseling is fifteen minutes and the bus leaves at four, and the sum of a million rational signatures is a society that has priced its own years, sold them at the low end of the market, and called the ledger healthcare.

Champaigne painted the whole argument in 1671, a tulip, a skull, and an hourglass set side by side on a bare stone shelf, life and death and time laid out like entries awaiting a ledger. The cure would make it a price list, the flower, the skull, the glass, and beneath them at last, in a clinician’s neat hand, the exchange rate, and the question , made ordinary, made clinical, printed in duplicate. How much of the length of your life will you pay for the rest of it?